MedPath

eurofeedback effect on 12-18 years of old ASD samples

Phase 1
Recruiting
Conditions
Autism Spectrum Disorders.
Autistic disorder
F84.0
Registration Number
IRCT20221012056157N1
Lead Sponsor
Hamedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Autism spectrum disorder subjects diagnosed with DSM-V criteria
Without neurological disorders
Age range of 12-18
Family satisfaction

Exclusion Criteria

Hearing loss, poor eyesight, Bilingual
Neurological disorder such as schizophrenia, epilepsy, Brain tumor

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Concentration. Timepoint: Before neurofeedback intervention, After 10 session neurofeedback intervention. Method of measurement: EEG analysis.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath